GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » Total Assets

Hangzhou Tigermed Consulting Co (SZSE:300347) Total Assets : ¥30,070 Mil (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Total Assets?

Hangzhou Tigermed Consulting Co's Total Assets for the quarter that ended in Mar. 2024 was ¥30,070 Mil.

Warning Sign:

If a company builds assets at 44.5% a year, faster than its revenue growth rate of 25.1% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Hangzhou Tigermed Consulting Co's average Total Assets Growth Rate was 10.20% per year. During the past 3 years, the average Total Assets Growth Rate was 33.40% per year. During the past 5 years, the average Total Assets Growth Rate was 44.50% per year. During the past 10 years, the average Total Assets Growth Rate was 48.90% per year.

During the past 13 years, Hangzhou Tigermed Consulting Co's highest 3-Year average Total Assets Growth Rate was 109.20%. The lowest was 33.40%. And the median was 51.70%.

Total Assets is connected with ROA %. Hangzhou Tigermed Consulting Co's annualized ROA % for the quarter that ended in Mar. 2024 was 3.15%. Total Assets is also linked to Revenue through Asset Turnover. Hangzhou Tigermed Consulting Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.06.


Hangzhou Tigermed Consulting Co Total Assets Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Total Assets Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,567.98 19,506.06 23,741.17 27,446.51 29,680.74

Hangzhou Tigermed Consulting Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28,172.13 29,666.68 30,072.45 29,680.74 30,070.19

Hangzhou Tigermed Consulting Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hangzhou Tigermed Consulting Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=24453.562+5227.18
=29,681

Hangzhou Tigermed Consulting Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=24533.292+5536.894
=30,070

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Tigermed Consulting Co  (SZSE:300347) Total Assets Explanation

Total Assets is connected with ROA %.

Hangzhou Tigermed Consulting Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=940.288/( (29680.742+30070.185)/ 2 )
=940.288/29875.4635
=3.15 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hangzhou Tigermed Consulting Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1660.204/( (29680.742+30070.185)/ 2 )
=1660.204/29875.4635
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hangzhou Tigermed Consulting Co Total Assets Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Executives
Directors, executives
Cao Xiao Chun Directors, executives
Executives
Ye Xiao Ping Director
Shi Xiao Li Supervisors
Wang Xiao Bo Supervisors
Li Xiao Ri Securities Affairs Representative
Xu Jia Lian Executives
Gong Yan Hua Director

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines